Takahiro Nakazawa, PhD (CEO, Founder)
Former CSO at AnGes, Inc., Former Head of Pharmaceutical Development Labs at Eli Lilly Japan, Former Expert Working Group member for ICH S6 guideline
Area of specialty: nonclinical (pharmacology, toxicology), drug development strategy
Masaki Okano
Former Project Leader at Bayer Japan
Area of specialty: project management, clinical development, regulatory strategy, in-license evaluation
Hiroshi Onodera, PhD
Former PMDA specialist, Former Expert Working Group member for ICH S9 guideline
Area of specialty: nonclinical (toxicology), regulatory strategy
Hidetomo Matsumoto
Former Clinical Project Leader at AstraZeneca Japan,
Area of specialty: project management, clinical development, regulatory strategy